Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
355.20
+1.14 (+0.32%)
Official Closing Price
Updated: 4:15 PM EDT, Jun 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
66
67
Next >
3 Worst Performing Dow Jones Stocks In 2024
↗
December 29, 2024
The Dow Jones Industrial Average will finish 2024 with a positive return. The index has climbed about 24% this year.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Looking At Amgen's Recent Unusual Options Activity
↗
December 27, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 26, 2024
Via
Benzinga
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
↗
December 23, 2024
The Schwab US Dividend Equity ETF has given back more than half of its one-year gains in the last month, with the ETF falling more than 7% in December. Here's a look at what may be plaguing the fund:
Via
Benzinga
Topics
ETFs
Spotlight on Amgen: Analyzing the Surge in Options Activity
↗
December 23, 2024
Via
Benzinga
2 Excellent Dividend Stocks to Buy on the Dip
↗
December 23, 2024
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Amgen
↗
December 12, 2024
Via
Benzinga
Demystifying Amgen: Insights From 13 Analyst Reviews
↗
December 10, 2024
Via
Benzinga
What's Going On With Amgen Stock On Friday?
↗
December 20, 2024
Novo Nordisk's CagriSema shows 22.7% weight loss in Phase 3 trials, while tolerability concerns grow. MariTide offers competitive weight loss with less frequent dosing.
Via
Benzinga
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
↗
December 20, 2024
The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.
Via
Investor's Business Daily
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
↗
December 20, 2024
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
Via
Investor's Business Daily
10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak
↗
December 19, 2024
Investors shrugged off the meltdown on Thursday. A few Dow laggards rebounded.
Via
Investor's Business Daily
Topics
Stocks
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
↗
December 16, 2024
The company's drug led to an improvement in diplopia, or double vision, an area where Amgen's Tepezza hasn't worked.
Via
Investor's Business Daily
Is Amgen Still a Top Dividend Stock?
↗
December 05, 2024
Via
The Motley Fool
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
↗
December 02, 2024
Via
The Motley Fool
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
↗
December 16, 2024
The weight-loss drugs space continues to heat up. Here's the latest news from the segment.
Via
Investor's Business Daily
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
↗
December 13, 2024
ICER's 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends.
Via
Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
↗
December 12, 2024
Via
The Motley Fool
Topics
Stocks
10 Health Care Stocks Whale Activity In Today's Session
↗
December 11, 2024
Via
Benzinga
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
↗
December 09, 2024
Via
The Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
↗
December 07, 2024
Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.
Via
The Motley Fool
Topics
Stocks
MarketBeat Week in Review – 12/2 - 12/6
December 07, 2024
Equities continued their post-election rally after Friday’s solid November jobs report and all signs point to the rally in stocks extending into 2025
Via
MarketBeat
Topics
Economy
Government
Immigration
Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?
December 06, 2024
Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.
Via
MarketBeat
13 Healthcare Sector Stocks With Healthy Valuation
↗
December 05, 2024
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...
Via
Talk Markets
Topics
Stocks
Stocks / Equities
10 Health Care Stocks Whale Activity In Today's Session
↗
December 05, 2024
Via
Benzinga
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
↗
December 05, 2024
Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.
Via
The Motley Fool
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
↗
December 04, 2024
Via
The Motley Fool
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
↗
December 03, 2024
Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a $100B market.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 02, 2024
Via
Benzinga
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
↗
November 30, 2024
Via
The Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
66
67
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
